openPR Logo
Press release

2023 Induced Pluripotent Stem Cell Market Report: Market Size, Trends, Share Analysis, Share and Industry Forecast To 2032 | Fujifilm Holding Corporation, Thermo Fisher Scientific Inc, Takara Bio Inc, ViaCyte, Fate Therapeutics

10-31-2023 08:29 AM CET | Health & Medicine

Press release from: The Business research company

Induced Pluripotent Stem Cell Market

Induced Pluripotent Stem Cell Market

As per The Business Research Company's Induced Pluripotent Stem Cell Opportunities And Strategies Market Report 2023, The global induced pluripotent stem cell (iPSC) market reached a value of nearly $2,223.5 million in 2020, having increased at a compound annual growth rate (CAGR) of 9.2% since 2015. The market is expected to grow from $2,223.5 million in 2020 to $3,362.1 million in 2025 at a rate of 8.6%. The induced pluripotent stem cell (iPSC) market is then expected to grow at a CAGR of 6.2% from 2025 and reach $4,547.7 million in 2030.  

Increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of Induced pluripotent stem cell market. Chronic disorders like heart disease, cancer, stroke, diabetes can be treated with Induced pluripotent stem cell. Induced Pluripotent stem cells are taken from any tissues from a child or an adult and are genetically modified to behave like embryonic stem cells. According to the report published by Partnership to Fight Chronic Disorder (PFCD), it was found that out of 133 Million Americans, 45% of the population had at least one chronic disorder. Moreover, it was estimated that 7 out of 10 deaths in the USA, which is approximately 1.7 million, are due to chronic disorders and these deaths can be controlled by induced pluripotent stem cell treatment. This rise in incidences of chronic diseases is expected to drive the demand for induced pluripotent stem cell treatment in the forecast period.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-market

Extensive research is being conducted on the use of induced pluripotent stem cells to treat Parkinson's disease (PD). Parkinson's disease (PD) is a neurodegenerative disorder that affects nerve cells involved in releasing dopamine. The reprogramming of mature cells from skin into induced pluripotent nerve cells which can produce dopamine can be a potential treatment for the Parkinson's disease (PD). In 2018, researchers from Kyoto University, Japan transplanted iPSC's into the brain of patient with Parkinson's disease (PD) which will act as precursors for nerve cells to produce dopamine.
The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by derived cell type will arise in the fibroblasts segment, which will gain $360.1 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by end-user industry will arise in the hospitals segment, which will gain $393.0 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by application will arise in the drug discovery and toxicity studies segment, which will gain $520.3 million of global annual sales by 2025. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $132.6 million.

Induced Pluripotent Stem Cell Market Segmentation:

The Induced Pluripotent Stem Cell market is segmented by derived cell type, by application, by end-use industry and by geography.

By Derived Cell Type -
The induced pluripotent stem cell (iPSC) market is segmented by derived cell type into
a) Hepatocytes
b) Fibroblasts
c) Keratinocytes
d) Amniotic Cells
e) Others

By Application -
The induced pluripotent stem cell (iPSC) market is segmented by application into
a) Academic Research
b) Drug Discovery And Toxicity Studies
c) Cell & Gene Therapy
d) Regenerative Medicine

By End-User -
The induced pluripotent stem cell (iPSC) market is segmented by end-user into
a) Research Laboratories
b) Hospitals

By Geography- The induced pluripotent stem cell (iPSC) market is segmented by geography into
o Asia Pacific
• China
• Japan
• India
• Australia
• Indonesia
• South Korea

Major players in the Induced Pluripotent Stem Cell market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc, Takara Bio Inc, ViaCyte, Fate Therapeutics

The regions covered in the global Induced Pluripotent Stem Cell market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=5197&type=smp

The latest report from The Business Research Company, 'Global Induced Pluripotent Stem Cell Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Induced Pluripotent Stem Cell Market Report Table Of Content

1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
……
19. Company Profiles
20. Key Mergers and Acquisitions
21. Opportunities And Strategies
22. Biotechnology Services Market, Conclusions And Recommendations
23. Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5197

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2023 Induced Pluripotent Stem Cell Market Report: Market Size, Trends, Share Analysis, Share and Industry Forecast To 2032 | Fujifilm Holding Corporation, Thermo Fisher Scientific Inc, Takara Bio Inc, ViaCyte, Fate Therapeutics here

News-ID: 3270205 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Induced

Evolving Market Trends In The Opioid-Induced Constipation Treatment Industry: St …
The Opioid-Induced Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Opioid-Induced Constipation Treatment Market Size During the Forecast Period? The opioid-induced constipation treatment market, valued at $1.78 billion in 2024, is projected to increase to $1.9 billion in 2025, growing
Chemotherapy Induced Anemia Market Size | Forecast
The new report published by The Business Research Company, titled Chemotherapy-Induced Anemia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the chemotherapy-induced anemia market size has grown strongly in recent years. It will grow from $2.4 billion in
Combating Chemotherapy-Induced Anemia: Market Projections 2024
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Chemotherapy-Induced Anemia Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $3.46 billion In 2028 At
Laser-Induced Breakdown Spectroscopy Market - Transforming Elemental Analysis: L …
Newark, New Castle, USA: The "Laser-Induced Breakdown Spectroscopy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Laser-Induced Breakdown Spectroscopy Market: https://www.growthplusreports.com/report/laserinduced-breakdown-spectroscopy-market/8556 This latest report researches the industry structure,
Induced Pluripotent Stem Cell Market: Factors Influencing the Growth Rate of Ind …
Researchmoz added most up-to-date research on "Global Market Study on Induced Pluripotent Stem Cell: APEC to Present Lucrative Research Opportunities to Vendors in Future" to its huge collection of research reports. Induced Pluripotent Stem Cell Market is expected to witness a strong CAGR of 7.0% from 2018 to 2026. In 2017, the market was worth US$ 1,254.0 Mn and is expected to reach US$ 2,299.5 Mn by the end of
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in